Showing results (241-250 of 369) with videos related to

Sort By:
Pageof 37
Pharmacology & Therapeutics|January 12, 2023
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectivesAlfredo Addeo, Ernesto Miranda-Morales, Petra den Hollander, et al.
Cancers|December 9, 2023
An Optimized Method to Culture Human Primary Lung Tumor Cell SpheroidsAmanda Mueggler, Eléa Pilotto, Nadja Perriraz-Mayer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2025
Adherence of published randomised Phase 3 cancer trials to principles proposed by common-sense oncologyOmar Abdihamid, Bishal Gyawali, Christopher M Booth, et al.
Ecancermedicalscience|July 3, 2023
Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activityManju Sengar, Wilma M Hopman, Ghulam Rehman Mohyuddin, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 1, 2026
Household income sources and mobility drivers of dietary diversity among refugees with hypertension and/or type 2 diabetes in Bidibidi Settlement, UgandaBishal Gyawali, Dricile Ratib, Tania Aase Dræbel, et al.
International Journal of Oncology|May 9, 2009
Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapyGraziella Bellone, Anna Novarino, Barbara Vizio, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II studyDiego Dongiovanni, Camilla Fissore, Alfredo Berruti, et al.
BMC Palliative Care|December 10, 2017
Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre studyAnna C Bibby, Duneesha De Fonseka, Anna J Morley, et al.
Expert Review of Respiratory Medicine|January 31, 2024
First-line immunotherapy in non-small cell lung cancer: how to select and where to goAndrea Mogavero, Ornella Cantale, Veronica Mollica, et al.
JAMA Network Open|April 16, 2024
Neoadjuvant Chemo-Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisGiuseppe Luigi Banna, Mona Ali Hassan, Alessio Signori, et al.
Pageof 37